Psychiatric implications of anti-seizure medications in epileptic population

被引:1
|
作者
Khalid, Bushra [1 ]
Waqar, Zaid [1 ]
Khan, Soban [1 ]
Ali, Ijaz [1 ]
Afzal, Naheed [1 ]
Irfan, Anum [1 ]
Malik, Waleed [1 ]
Adil, Malik Muhammad [1 ]
Saddiqa, Amina [1 ]
Khalil, Maryam [1 ]
Munawar, Zeeshan [1 ]
机构
[1] Pakistan Inst Med Sci, Islamabad, Pakistan
关键词
Epilepsy; Antiseizure medications; Psychiatric comorbidities; Valproate; MRI findings; DEPRESSION; CLASSIFICATION; COMORBIDITIES; DEFINITION; ILAE;
D O I
10.1186/s12883-024-03670-8
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and objective Epilepsy is a prevalent neurological disorder that affects a significant number of individuals globally. This condition is associated with a high occurrence of psychiatric comorbidities, which can significantly affect the quality of life of individuals affected. The aim of this study was to investigate the association between antiseizure therapies and the likelihood of psychiatric comorbidities in individuals with epilepsy.Methodology Data for this study was gathered from the Neurology referral center in Islamabad, Pakistan. A standardized questionnaire was utilized to gather data from 120 individuals diagnosed with epilepsy. The survey consisted of inquiries regarding the management of seizures, the utilization of anti-seizure medications, and the presence of psychiatric comorbidities. The data was analyzed using the Statistical Package for the Social Sciences (SPSS).Results The findings indicated that individuals who were using multiple antiseizure medications had a notably higher likelihood of having psychiatric comorbidities in comparison to those who were on mono therapy (p = 0.010). suggests that patients with unsuccessful seizure control are more probable to have psychiatric comorbidities as compared to those with good seizure control (p = 0.029).Conclusion To conclude poor seizure control and poly therapy are associated with increased risk of psychiatric comorbidities.
引用
收藏
页数:5
相关论文
共 50 条
  • [31] The effect of anti-seizure medications on lipid values in adults with epilepsy
    Muller, Ashley L.
    Diaz-Arias, Luisa
    Cervenka, Mackenzie C.
    Mcdonald, Tanya J. W.
    EPILEPSY & BEHAVIOR, 2023, 144
  • [33] What You Don't Know Can Hurt You: Psychiatric Effects of Prenatal Anti-Seizure Medications
    Terman, Samuel W.
    EPILEPSY CURRENTS, 2023, 23 (06) : 366 - 368
  • [34] Gut microbiota signature may predict response to anti-seizure medications
    Riva, A.
    Sahin, E.
    Volpedo, G.
    Balagura, G.
    Russo, E.
    Zara, F.
    Striano, P.
    EPILEPSIA, 2024, 65 : 405 - 406
  • [35] MOLECULAR AND GENETIC MECHANISMS OF NEUROTOXICITY DURING ANTI-SEIZURE MEDICATIONS USE
    Rubio, Carmen
    Gatica, Fernando
    Uribe, Eric
    Ochoa, Ernesto
    Campos, Victoria
    Rubio-Osornio, Moises
    REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 2023, 75 (01): : 1 - 12
  • [36] Management of Anti-Seizure Medications during Pregnancy: Advancements in The Past Decade
    Avachat, Charul
    Barry, Jessica M.
    Lyu, Xintian
    Sherwin, Catherine M.
    Birnbaum, Angela K.
    PHARMACEUTICS, 2022, 14 (12)
  • [37] Anti-seizure medications and risk of suicide: Re-addressing the issue
    Gudi, Sai Krishna
    Jahan, Qaiser
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2021, 75 (08)
  • [38] Anti-Seizure Medications on Trial Again: Accused of Parkinson's Disease!
    Sarkis, Rani A.
    EPILEPSY CURRENTS, 2023, 23 (05) : 277 - 279
  • [39] Assessment of clinically actionable pharmacogenetic markers to stratify anti-seizure medications
    Guin, Debleena
    Hasija, Yasha
    Kukreti, Ritushree
    PHARMACOGENOMICS JOURNAL, 2023, 23 (06): : 149 - 160
  • [40] Assessment of clinically actionable pharmacogenetic markers to stratify anti-seizure medications
    Debleena Guin
    Yasha Hasija
    Ritushree Kukreti
    The Pharmacogenomics Journal, 2023, 23 (6) : 149 - 160